We are live on ! Find out more
CKPT

Checkpoint Therapeutics
CKPT

Delisted

CKPT was delisted on the 29th of May, 2025.

Back to rankings

40 hedge funds and large institutions have $23.4M invested in Checkpoint Therapeutics in 2022 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 16 increasing their positions, 10 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

667% more call options, than puts

Call options by funds: $391K | Put options by funds: $51K

85% more capital invested

Capital invested by funds: $12.6M → $23.4M (+$10.8M)

60% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 10

20.87% more ownership

Funds ownership: 1.33% → 22.2% (+21%)

30% less funds holding

Funds holding: 57 → 40 (-17)

61% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 23

Holders
40
Holders Change
-17
Holders Change %
-29.82%
% of All Funds
0.64%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
16
Reduced
10
Closed
23
Calls
$391K
Puts
$51K
Net Calls
+$340K
Net Calls Change
+$886K

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$4.98M
2
Bank of America
Bank of America
North Carolina
+$1.45M
3
TC
TwinBeech Capital
New York
+$815K
4
PAS
Park Avenue Securities
New York
+$256K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$256K

Top Sellers

Rank Fund Capital Flow
1
BBA
Baader Bank Aktiengesellschaft
Germany
-$917K
2
Renaissance Technologies
Renaissance Technologies
New York
-$372K
3
GCP
GSA Capital Partners
United Kingdom
-$364K
4
Millennium Management
Millennium Management
New York
-$132K
5
RJFSA
Raymond James Financial Services Advisors
Florida
-$86K
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
26
UBS Group
Switzerland
$19.4K +$5.27K +731 +24%
Morgan Stanley
27
Morgan Stanley
New York
$5.94K -$10.8K -1,499 -56%
Fidelity Investments
28
Fidelity Investments
Massachusetts
$4.54K +$6.41K +889 New
TWM
29
Tradition Wealth Management
Minnesota
$4K – – –
LAM
30
Lakewood Asset Management
Illinois
$3K +$4.18K +580 New
Rockefeller Capital Management
31
Rockefeller Capital Management
New York
$2K -$7 -1 -0.2%
TFGT
32
TS Financial Group (TSFG)
Illinois
$2K – – –
TFS
33
TrustCore Financial Services
Tennessee
$792 – – –
BAM
34
Belpointe Asset Management
Nevada
$435 +$612 +85 New
Citadel Advisors
35
Citadel Advisors
Florida
$327 -$11.5K -1,598 -96%
FCA
36
Fortis Capital Advisors
Kansas
$266 +$375 +52 New
Wells Fargo
37
Wells Fargo
California
$250 +$7 +1 +2%
NA
38
NewEdge Advisors
Louisiana
$56 +$79.2K +11,000 New
FGAM
39
Financial Gravity Asset Management
Texas
$46 +$36 +5 New
Renaissance Technologies
40
Renaissance Technologies
New York
– -$372K -35,750 Closed
GCP
41
GSA Capital Partners
United Kingdom
– -$364K -34,986 Closed
BBA
42
Baader Bank Aktiengesellschaft
Germany
– -$917K -8,820 Closed
RJFSA
43
Raymond James Financial Services Advisors
Florida
– -$86K -8,256 Closed
Two Sigma Advisers
44
Two Sigma Advisers
New York
– -$83K -8,010 Closed
AI
45
Atom Investors
Texas
– -$71K -6,873 Closed
T. Rowe Price Associates
46
T. Rowe Price Associates
Maryland
– -$62K -5,900 Closed
Two Sigma Investments
47
Two Sigma Investments
New York
– -$48K -4,610 Closed
Bank of New York Mellon
48
Bank of New York Mellon
New York
– -$44K -4,232 Closed
Charles Schwab
49
Charles Schwab
California
– -$36K -3,371 Closed
OAM
50
Occidental Asset Management
California
– -$27K -2,640 Closed
1
2
3

CKPT Hedge Fund Activity: Q4 2022 in Review

40 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Checkpoint Therapeutics (CKPT) for Q4 2022, worth a combined $23.4M — up 85% from $12.6M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of CKPT and 9 opened new positions — a net loss of 14 holders — while 10 trimmed existing stakes and 16 added.

The largest buyer was Armistice Capital, opening a new position worth an estimated $4.98M. The largest seller was Baader Bank Aktiengesellschaft, exiting entirely with an estimated $917K sold.

  • 40 institutional investors held Checkpoint Therapeutics (CKPT) as of Q4 2022, down from 57 in Q3 2022.
  • Funds reported $23.4M of Checkpoint Therapeutics stock for Q4 2022, up 85% quarter-over-quarter.
  • 9 funds opened new Checkpoint Therapeutics positions in Q4 2022 and 23 closed out, a net change of -14 holders.
  • The largest Checkpoint Therapeutics buyer in Q4 2022 was Armistice Capital, an estimated $4.98M added.
  • The largest Checkpoint Therapeutics seller in Q4 2022 was Baader Bank Aktiengesellschaft, an estimated $917K sold.

Based on aggregated 13F filings for Q4 2022.